|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
D
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Hepatotoxicity |
|
Endometrial hyperplasia |
|
hypercalcemia |
|
ocular toxicity, including abnormal visual fields, cataracts, corneal keratopathy, glaucoma |
|
Cardiac failure |
|
myocardial infarction |
|
pulmonary embolus |
|
thrombophlebitis or thrombosis |
|
Hot flashes |
|
nausea |
|
Dizziness |
|
dry eyes |
|
tumor flare |
|
vomiting |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Bone metastases |
|
>> Endometrial hyperplasia, pre-existing |
|
Leukopenia |
|
Thrombocytopenia |
|
|
ADULT DOSE:
|
|
Breast carcinoma-
Oral, 60 mg (base) once a day . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Breast carcinoma-
Oral, 60 mg (base) once a day . |
|
|
|
|
|